跳轉至內容
Merck
全部照片(1)

Key Documents

810891C

Avanti

DSPE PEG(2000)-N-Cy5

Avanti Polar Lipids, chloroform solution

同義詞:

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000]-N-(Cyanine 5)

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C164H299N4O55P
CAS號碼:
分子量::
3238.10
分類程式碼代碼:
12352211

化驗

99% (TLC)

形狀

chloroform solution

包裝

pkg of 1 × 1 mg (
810891C-1MG)

pkg of 5 × 1 mg (
810891C-5MG)

製造商/商標名

Avanti Polar Lipids

濃度

1 mg/mL (810891C-1MG)
1 mg/mL (810891C-5MG)

運輸包裝

dry ice

儲存溫度

−20°C

應用

DSPE PEG(2000)-N-Cy5 is suitable for use to ensure the proper insertion of folic acid to red blood cells (RBCs) membrane by fluorescence microscopy.

生化/生理作用

DSPE PEG(2000)-N-Cy5 is used in the preparation of folic acid and Cy5 modified red blood cells (RBCs) vesicles (FRVs). DSPE PEG(2000)-N-Cy5 is used to demonstrate the modification of RBCs membrane with folic acid. After mixing DSPE PEG(2000)-N-Cy5 with RBC, the non-luminous membrane exhibits bright Cy5 fluorescence, enables visualization with fluorescence microscope.

包裝

5ML Clear Glass Sealed Ampule (810891C-1MG)
5ML Clear Glass Sealed Ampule (810891C-5MG)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

象形圖

Skull and crossbonesHealth hazard

訊號詞

Danger

危險分類

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3

標靶器官

Central nervous system

儲存類別代碼

6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Engineered red blood cells for capturing circulating tumor cells with high performance
Zhu DM, et al.
Nanoscale, 10(13), 6014-6023 (2018)
Erythrocyte derived vesicles for circulating tumor cells capturing and specific tumor imaging
Liu A, et al.
Nanoscale, 11, 12388-12396 (2019)
Ming Chen et al.
Nanoscale, 11(25), 12388-12396 (2019-06-20)
The precise diagnosis of cancer remains a great challenge; therefore, it is our research interest to develop safe, tumor-specific reagents. In this study, we designed nanovesicles derived from erythrocyte membranes; the nanovesicles are capable of recognizing tumor cells for both

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務